MedTrace Logo

Guaranteed Income to Boost HIV Care Continuity and Suppression Post-Jail Release

NCT07115901 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2026-03-13

No results posted yet for this study

Summary

The goal of this clinical trial is to understand the implementation requirements and potential health impacts of a guaranteed income (GI) intervention targeting people living with HIV with criminal legal involvement (PWH-CLI). The main questions it aims to answer are:

* How acceptable is a GI intervention, and its intervention components, among PWH-CLI participants and stakeholders?
* How feasible is a GI intervention for PWH-CLI? What are the implementation barriers and opportunities for this intervention?
* What is the preliminary efficacy of the GI intervention on improving HIV care outcomes for PWH-CLI? Researches will compare study engagement and study outcomes across three randomization arms (A: receive full GI amount as one lump sum payment; B: receive full GI amount split over nine monthly installments; C: participant chooses whether to receive GI as lump sum payment or monthly installments). HIV care outcomes will be compared against a retrospective cohort of PWH-CLI patients as historical controls.

Participants will:

* Be randomized to receive GI intervention as a lump sum payment or monthly installment (over nine months) or choose their preference.
* Complete 3 surveys throughout study follow up to assess experience with the intervention, experience with social services and benefits programs, experience with the criminal legal system, and HIV care outcomes.
* Be interviewed by the research team to further understand the experience with the intervention.

Conditions

  • HIV (Human Immunodeficiency Virus)

Interventions

OTHER

Lump sum

Participants receive guaranteed income (GI) to the amount of $6,750 as a one-time lump sum payment.

OTHER

Monthly installments

Participants receive guaranteed income (GI) to the total amount of $6,750 as 9-monthly installments of $750 per month

OTHER

Choice

Participants choose which method of guaranteed income disbursement they will receive (lump sum or monthly installment)

Sponsors & Collaborators

Principal Investigators

  • Paul D Wesson, PhD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2027-02-25
Completion
2027-02-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07115901 on ClinicalTrials.gov